Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 May;11(5):518–520. doi: 10.1111/j.1365-2125.1981.tb01160.x

Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA).

D W Harron, R G Shanks
PMCID: PMC1401607  PMID: 7272165

Full text

PDF
518

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown H. C., Carruthers S. G., Johnston G. D., Kelly J. G., McAinsh J., McDevitt D. G., Shanks R. G. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther. 1976 Nov;20(5):524–534. doi: 10.1002/cpt1976205524. [DOI] [PubMed] [Google Scholar]
  2. Brown H. C., Carruthers S. G., Kelly J. G., McDevitt D. G., Shanks R. G. Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):367–372. doi: 10.1007/BF00606550. [DOI] [PubMed] [Google Scholar]
  3. Degen P. H., Riess W. Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography. J Chromatogr. 1976 Jun 9;121(1):72–75. doi: 10.1016/s0021-9673(00)82299-2. [DOI] [PubMed] [Google Scholar]
  4. Douglas-Jones A. P., Baber N. S., Lee A. Once daily propranolol in the treatment of mild to moderate hypertension: a dose range finding study. Eur J Clin Pharmacol. 1978 Nov 27;14(3):163–166. doi: 10.1007/BF02089954. [DOI] [PubMed] [Google Scholar]
  5. Dreyfuss J., Brannick L. J., Vukovich R. A., Shaw J. M., Willard D. A. Metabolic studies in patients with nadolol: oral and intravenous administration. J Clin Pharmacol. 1977 May-Jun;17(5-6):300–307. doi: 10.1002/j.1552-4604.1977.tb04609.x. [DOI] [PubMed] [Google Scholar]
  6. Ervik M. Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):136–144. doi: 10.1111/j.1600-0773.1975.tb03330.x. [DOI] [PubMed] [Google Scholar]
  7. Frick M. H., Kala R. Once daily versus twice daily beta-blockers: effects on arrhythmias and hypertension. Lancet. 1980 Sep 13;2(8194):588–588. doi: 10.1016/s0140-6736(80)92020-6. [DOI] [PubMed] [Google Scholar]
  8. Johnsson G., Jordö L., Lundborg P., Regårdh C. G., Rönn O. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers. Int J Clin Pharmacol Ther Toxicol. 1980 Jul;18(7):292–297. [PubMed] [Google Scholar]
  9. Kendall M. J., John V. A., Quarterman C. P., Welling P. G. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. Eur J Clin Pharmacol. 1980 Feb;17(2):87–92. doi: 10.1007/BF00562615. [DOI] [PubMed] [Google Scholar]
  10. Leahey W. J., Neill J. D., Varma M. P., Shanks R. G. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur J Clin Pharmacol. 1980 Jun;17(6):419–424. doi: 10.1007/BF00570158. [DOI] [PubMed] [Google Scholar]
  11. Leahey W. J., Neill J. D., Varma M. P., Shanks R. G. Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. Br J Clin Pharmacol. 1980 Jan;9(1):33–40. doi: 10.1111/j.1365-2125.1980.tb04793.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Quaterman C. P., Kendall M. J., Welling P. G. Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation. Eur J Clin Pharmacol. 1979 Mar 26;15(2):97–103. doi: 10.1007/BF00609871. [DOI] [PubMed] [Google Scholar]
  13. Reybrouck T., Amery A., Fagard R., Jousten P., Lijnen P., Meulepas E. Beta-blockers: once or three times a day? Br Med J. 1978 May 27;1(6124):1386–1388. doi: 10.1136/bmj.1.6124.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES